FDA lifts hold on Arcellx’s Gilead-partnered cancer cell therapy
BioPharma Dive,
Dive Brief: The Food and Drug Administration is allowing biotechnology company Arcellx to resume a clinical trial of a Gilead-par…
Episode 5: CAR T-Cell Therapy for Multiple Myeloma
Medscape,
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple…
Patient death spurs FDA to pause test of Arcellx’s Gilead-partnered cell therapy
BioPharma Dive,
Dive Brief: The Food and Drug Administration has paused a Phase 2 trial of a cell therapy Arcellx is developing for multiple…
Episode 3: CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
Medscape,
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple…